{"id":"https://openalex.org/W2856796550","doi":"https://doi.org/10.1038/s41598-018-28449-z","title":"Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson\u2019s disease","display_name":"Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson\u2019s disease","alternate_titles":[],"publication_year":2018,"publication_date":"2018-07-16","ids":{"openalex":"https://openalex.org/W2856796550","doi":"https://doi.org/10.1038/s41598-018-28449-z","mag":"2856796550","pmid":"https://pubmed.ncbi.nlm.nih.gov/30013201","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6048117"},"language":"en","primary_location":{"id":"doi:10.1038/s41598-018-28449-z","doi":"https://doi.org/10.1038/s41598-018-28449-z","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-018-28449-z","pdf_url":"https://www.nature.com/articles/s41598-018-28449-z.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2856796550"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41598-018-28449-z.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102849935","display_name":"Shuchun Chen","orcid":"https://orcid.org/0000-0002-7747-3901","observed_orcids":["https://orcid.org/0000-0002-7747-3901"]},"institutions":[{"id":"https://openalex.org/I114150738","display_name":"Fu Jen Catholic University","ror":"https://ror.org/04je98850","country_code":"TW","type":"education","lineage":["https://openalex.org/I114150738"]},{"id":"https://openalex.org/I165441096","display_name":"National Health Research Institutes","ror":"https://ror.org/02r6fpx29","country_code":"TW","type":"nonprofit","lineage":["https://openalex.org/I165441096"]}],"countries":["TW"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shuchun Chen","raw_affiliation_strings":["Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan","Graduate Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan","institution_ids":["https://openalex.org/I165441096"]},{"raw_affiliation_string":"Graduate Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei, Taiwan","institution_ids":["https://openalex.org/I114150738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011962611","display_name":"Seong\u2010Jin Yu","orcid":"https://orcid.org/0000-0001-7500-5883","observed_orcids":["https://orcid.org/0000-0001-7500-5883"]},"institutions":[{"id":"https://openalex.org/I165441096","display_name":"National Health Research Institutes","ror":"https://ror.org/02r6fpx29","country_code":"TW","type":"nonprofit","lineage":["https://openalex.org/I165441096"]}],"countries":["TW"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Seong-Jin Yu","raw_affiliation_strings":["Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan","institution_ids":["https://openalex.org/I165441096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100669061","display_name":"Yazhou Li","orcid":"https://orcid.org/0000-0002-6048-3660","observed_orcids":["https://orcid.org/0000-0002-6048-3660"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yazhou Li","raw_affiliation_strings":["Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108473206","display_name":"Daniela Lecca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniela Lecca","raw_affiliation_strings":["Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012561586","display_name":"Elliot J. Glotfelty","orcid":"https://orcid.org/0000-0001-5125-8720","observed_orcids":["https://orcid.org/0000-0001-5125-8720"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elliot Glotfelty","raw_affiliation_strings":["Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027797290","display_name":"Hee Kyung Kim","orcid":"https://orcid.org/0000-0002-7446-476X","observed_orcids":["https://orcid.org/0000-0002-7446-476X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hee Kyung Kim","raw_affiliation_strings":["Peptron Inc., Yuseong-gu, Daejeon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peptron Inc., Yuseong-gu, Daejeon, Republic of Korea","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076063185","display_name":"Hoil Choi","orcid":"https://orcid.org/0000-0002-8847-3835","observed_orcids":["https://orcid.org/0000-0002-8847-3835"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ho-Il Choi","raw_affiliation_strings":["Peptron Inc., Yuseong-gu, Daejeon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peptron Inc., Yuseong-gu, Daejeon, Republic of Korea","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086984046","display_name":"Barry J. Hoffer","orcid":"https://orcid.org/0000-0002-1122-9025","observed_orcids":["https://orcid.org/0000-0002-1122-9025"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Barry J. Hoffer","raw_affiliation_strings":["Department of Neurosurgery, Case Western Reserve University School of Medicine, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosurgery, Case Western Reserve University School of Medicine, Cleveland, OH, USA","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056649584","display_name":"Nigel H. Greig","orcid":"https://orcid.org/0000-0002-3032-1468","observed_orcids":["https://orcid.org/0000-0002-3032-1468"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nigel H. Greig","raw_affiliation_strings":["Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA. Greign@mail.nih.gov","Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA. Greign@mail.nih.gov","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]},{"raw_affiliation_string":"Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100759180","display_name":"Dong Seok Kim","orcid":"https://orcid.org/0000-0001-5637-2469","observed_orcids":["https://orcid.org/0000-0001-5637-2469"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dong Seok Kim","raw_affiliation_strings":["Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA","Peptron Inc., Yuseong-gu, Daejeon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]},{"raw_affiliation_string":"Peptron Inc., Yuseong-gu, Daejeon, Republic of Korea","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100377602","display_name":"Yun Wang","orcid":"https://orcid.org/0000-0001-7983-5905","observed_orcids":["https://orcid.org/0000-0001-7983-5905"]},"institutions":[{"id":"https://openalex.org/I165441096","display_name":"National Health Research Institutes","ror":"https://ror.org/02r6fpx29","country_code":"TW","type":"nonprofit","lineage":["https://openalex.org/I165441096"]}],"countries":["TW"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yun Wang","raw_affiliation_strings":["Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan. ywang@nhri.org.tw","Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan. ywang@nhri.org.tw","institution_ids":["https://openalex.org/I165441096"]},{"raw_affiliation_string":"Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan","institution_ids":["https://openalex.org/I165441096"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5056649584","https://openalex.org/A5100377602"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I165441096","https://openalex.org/I4210136897"],"apc_list":{"value":2690,"currency":"USD","value_usd":2690},"apc_paid":{"value":2690,"currency":"USD","value_usd":2690},"fwci":4.5084,"has_fulltext":true,"cited_by_count":73,"citation_normalized_percentile":{"value":0.95735978,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"8","issue":"1","first_page":"10722","last_page":"10722"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exendin-4","display_name":"exendin-4","score":0.8500000238418579},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.8600000143051147},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.8970000147819519},{"id":"https://openalex.org/keywords/6-ohda-lesion","display_name":"6-hydroxydopamine lesion","score":0.9120000004768372},{"id":"https://openalex.org/keywords/dopaminergic-neuron-degeneration","display_name":"dopaminergic neuron loss","score":0.9919999837875366},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8989999890327454},{"id":"https://openalex.org/keywords/tyrosine-hydroxylase","display_name":"tyrosine hydroxylase","score":0.9580000042915344},{"id":"https://openalex.org/keywords/substantia-nigra","display_name":"substantia nigra","score":0.9419999718666077},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.996999979019165},{"id":"https://openalex.org/keywords/nigrostriatal-pathway","display_name":"nigrostriatal pathway","score":0.7310000061988831},{"id":"https://openalex.org/keywords/long-acting-drug-delivery","display_name":"long-acting drug delivery","score":0.7519999742507935}],"concepts":[{"id":"https://openalex.org/C2911016594","wikidata":"https://www.wikidata.org/wiki/Q15946111","display_name":"Hydroxydopamine","level":4,"score":0.9666838049888611},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.8508749604225159},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.8231618404388428},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.7059925198554993},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5714223384857178},{"id":"https://openalex.org/C2777288102","wikidata":"https://www.wikidata.org/wiki/Q780181","display_name":"Oxidopamine","level":5,"score":0.5370228886604309},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5280198454856873},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.45865651965141296},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4447677731513977},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3310386538505554},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23521199822425842},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23250171542167664},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.17477953433990479}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014446","descriptor_name":"Tyrosine 3-Monooxygenase","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015632","descriptor_name":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016627","descriptor_name":"Oxidopamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016627","descriptor_name":"Oxidopamine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D059290","descriptor_name":"Dopaminergic Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D059290","descriptor_name":"Dopaminergic Neurons","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D059290","descriptor_name":"Dopaminergic Neurons","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1038/s41598-018-28449-z","doi":"https://doi.org/10.1038/s41598-018-28449-z","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-018-28449-z","pdf_url":"https://www.nature.com/articles/s41598-018-28449-z.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5006066","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6048117","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6048117","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6048117/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sci Rep","raw_type":"Text"},{"id":"pmid:30013201","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30013201","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific reports","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:2205535ea071492c8064aaeff8f1ee7e","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/2205535ea071492c8064aaeff8f1ee7e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41598-018-28449-z","doi":"https://doi.org/10.1038/s41598-018-28449-z","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-018-28449-z","pdf_url":"https://www.nature.com/articles/s41598-018-28449-z.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4274783216","display_name":"Repositioning Gliptins for Parkinson's Disease Treatment","funder_award_id":"R01NS094152","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G559921964","display_name":null,"funder_award_id":"S2174574","funder_id":"https://openalex.org/F4320334880","funder_display_name":"Small and Medium Business Administration"},{"id":"https://openalex.org/G6980982090","display_name":null,"funder_award_id":"094152","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G7573641038","display_name":null,"funder_award_id":"\u22122320","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320320671","display_name":"National Research Foundation","ror":"https://ror.org/05s0g1g46"},{"id":"https://openalex.org/F4320322030","display_name":"Ministry of Science, ICT and Future Planning","ror":"https://ror.org/032e49973"},{"id":"https://openalex.org/F4320322845","display_name":"National Health Research Institutes","ror":"https://ror.org/02r6fpx29"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320334880","display_name":"Small and Medium Business Administration","ror":"https://ror.org/022c4zk48"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2856796550.pdf","grobid_xml":"https://content.openalex.org/works/W2856796550.grobid-xml"},"referenced_works_count":68,"referenced_works":["https://openalex.org/W62603772","https://openalex.org/W140346588","https://openalex.org/W1535374793","https://openalex.org/W1539187429","https://openalex.org/W1546941007","https://openalex.org/W1963260622","https://openalex.org/W1964634933","https://openalex.org/W1966872231","https://openalex.org/W1967442749","https://openalex.org/W1971911315","https://openalex.org/W1980142052","https://openalex.org/W1980147075","https://openalex.org/W1993072922","https://openalex.org/W1993377651","https://openalex.org/W1998882505","https://openalex.org/W2001808016","https://openalex.org/W2003918243","https://openalex.org/W2004416309","https://openalex.org/W2006568691","https://openalex.org/W2050726283","https://openalex.org/W2057374599","https://openalex.org/W2057410639","https://openalex.org/W2063504754","https://openalex.org/W2069884615","https://openalex.org/W2073996535","https://openalex.org/W2076140273","https://openalex.org/W2077521501","https://openalex.org/W2079878023","https://openalex.org/W2080785707","https://openalex.org/W2090012352","https://openalex.org/W2096215923","https://openalex.org/W2102071852","https://openalex.org/W2123319002","https://openalex.org/W2127558621","https://openalex.org/W2138389486","https://openalex.org/W2139084760","https://openalex.org/W2141121157","https://openalex.org/W2147136484","https://openalex.org/W2149284026","https://openalex.org/W2161461930","https://openalex.org/W2164948885","https://openalex.org/W2170141518","https://openalex.org/W2211963426","https://openalex.org/W2263150733","https://openalex.org/W2270971263","https://openalex.org/W2332435010","https://openalex.org/W2333401592","https://openalex.org/W2395478387","https://openalex.org/W2419264752","https://openalex.org/W2481634574","https://openalex.org/W2486980624","https://openalex.org/W2550011910","https://openalex.org/W2566590101","https://openalex.org/W2567441913","https://openalex.org/W2572949702","https://openalex.org/W2584311212","https://openalex.org/W2589420593","https://openalex.org/W2597203198","https://openalex.org/W2606047586","https://openalex.org/W2609107212","https://openalex.org/W2621950860","https://openalex.org/W2658739663","https://openalex.org/W2743905715","https://openalex.org/W2744843428","https://openalex.org/W2755617272","https://openalex.org/W2756066122","https://openalex.org/W2759370326","https://openalex.org/W2776757037"],"related_works":["https://openalex.org/W3048449568","https://openalex.org/W3136655759","https://openalex.org/W2152209935","https://openalex.org/W3115238694","https://openalex.org/W2164948885","https://openalex.org/W2102071852","https://openalex.org/W7160348788","https://openalex.org/W2067453575","https://openalex.org/W3151452762","https://openalex.org/W4409825254"],"abstract_inverted_index":{"We":[0],"previously":[1],"demonstrated":[2],"that":[3,172],"pretreatment":[4],"with":[5,102,174],"Exendin-4,":[6],"a":[7,44,52,150,188,195],"glucagon-like":[8],"peptide-1":[9],"(GLP-1)":[10],"receptor":[11],"agonist,":[12],"reduces":[13,181],"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine":[14],"(MPTP)":[15],"-mediated":[16],"dopaminergic":[17,185],"neurodegeneration.":[18],"The":[19,36],"use":[20],"of":[21,38,55,59,65,127,183,192],"GLP-1":[22],"or":[23,93],"Exendin-4":[24,48,66,129,155,178],"for":[25,69,125],"Parkinson's":[26],"disease":[27],"(PD)":[28],"patients":[29],"is":[30],"limited":[31],"by":[32],"their":[33],"short":[34],"half-lives.":[35],"purpose":[37],"this":[39,81],"study":[40],"was":[41,149],"to":[42],"evaluate":[43],"new":[45],"extended":[46],"release":[47,179],"formulation,":[49],"PT302,":[50],"in":[51,62,67,72,141,159,187],"rat":[53,190],"model":[54,191],"PD.":[56],"Subcutaneous":[57],"administration":[58],"PT302":[60,86,103,113,137,175],"resulted":[61],"sustained":[63],"elevations":[64],"plasma":[68,128,154],">20":[70],"days":[71],"adult":[73],"rats.":[74],"To":[75],"define":[76],"an":[77],"efficacious":[78],"dose":[79],"within":[80],"range,":[82],"rats":[83],"were":[84,120],"administered":[85],"once":[87],"every":[88],"2":[89],"weeks":[90],"either":[91],"before":[92],"following":[94],"the":[95,142,160,166],"unilaterally":[96],"6-hydroxydopamine":[97,189],"lesioning.":[98,109],"Pre-":[99],"and":[100,117,131,146,157,163,180],"post-treatment":[101,173],"significantly":[104,138],"reduced":[105],"methamphetamine-induced":[106],"rotation":[107],"after":[108],"For":[110],"animals":[111],"given":[112],"post":[114],"lesion,":[115],"blood":[116],"brain":[118,132],"samples":[119],"collected":[121],"on":[122,165],"day":[123],"47":[124],"measurements":[126],"levels":[130,156],"tyrosine":[133],"hydroxylase":[134],"immunoreactivity":[135],"(TH-IR).":[136],"increased":[139],"TH-IR":[140,158],"lesioned":[143,167],"substantia":[144,161],"nigra":[145,162],"striatum.":[147],"There":[148],"significant":[151],"correlation":[152],"between":[153],"striatum":[164],"side.":[168],"Our":[169],"data":[170],"suggest":[171],"provides":[176],"long-lasting":[177],"neurodegeneration":[182],"nigrostriatal":[184],"neurons":[186],"PD":[193],"at":[194],"clinically":[196],"relevant":[197],"dose.":[198]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2856796550","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-07-19T00:00:00"}
